Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSCAB: Oral vs Intravenous Tranexamic Acid in Off-Pump CABG
2026-526581-24-01Phase 4Authorised
- Sponsor
- Santé et Prévoyance
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in coronary arteriosclerosis (2 arms), sponsored by Santé et Prévoyance. Primary endpoint: Cumulative postoperative chest-tube drainage within 24 hours after surgery. Planned start Jul 2026; status: authorised.
02
Drugs
tranexamic acid
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2026-526581-24-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526581-24-01.